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Summary
Stem cells undergo extensive metabolic rewiring during reprogramming, proliferation and 
differentiation, and numerous studies have demonstrated a significant role of metabolism in 
controlling stem cell fates. Recent applications of metabolomics, the study of concentrations and 
fluxes of small molecules in cells, have advanced efforts to characterize and maturate stem cell 
fates, assess drug toxicity in stem cell tissue models, identify biomarkers, and study the effects of 
environment on metabolic pathways in stem cells and their progeny. Looking to the future, 
combining metabolomics with other -omics approaches will provide a deeper understanding of the 
complex regulatory mechanisms of stem cells.
Introduction
Pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced 
pluripotent stem cells (iPSCs) have the ability to self-renew indefinitely and differentiate to 
any of the three germ layers [1,2]. In addition to potential applications in regenerative 
therapies, PSCs provide opportunities to model developmental progression and disease 
phenotypes, and can be used for drug screening and toxicity testing applications [3]. Major 
challenges to achieving the full potential of PSCs include identifying conditions that 
maintain their stemness and developing processes that effectively differentiate and mature 
PSCs to desired specialized cell types [3]. Another challenge is the development of 
phenotypic assays that employ stem cell-derived cells and tissues to expedite the process of 
drug screening and also provide mechanistic understanding of drug effects on human 
systems.
Metabolism and associated epigenetic remodeling have been found to play a crucial role in 
maintaining human PSC (hPSC) stemness and regulating differentiation [4–9••]. 
Metabolomics, the study of the complete set of small molecules or metabolites in a cell, is a 
reproducible, accurate and sensitive tool to analyze metabolic changes [10]. Metabolomics 
can also classify different cell types based on their molecular signatures [11], identify 
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metabolite biomarkers in biological samples [12], and assess the effects of different drugs on 
cells and tissues [13]. In this review, we will highlight advances in applications of 
metabolomics in the PSC field in the past five years and discuss the challenges and future 
directions in employing metabolomics to advance in vitro and in vivo applications of PSCs.
Metabolite regulation of stem cell fate
Metabolism plays a crucial role in PSC survival, proliferation, and differentiation. 
Alterations in energy requirements during PSC homeostasis and differentiation can lead to 
significant changes in metabolic pathway utilization [14]. Specifically, during and after 
reprogramming to iPSCs, glycolysis is the predominant pathway for ATP generation and this 
is essential for hPSC maintenance and self-renewal [14,15]. Aerobic glycolysis is also 
common in other rapidly proliferating cells including cancer cells [16]. A hypotheses for 
utilization of aerobic glycolosis for energy generation in cancer cells is that glycolytic 
intermediates are used for nucleotide and protein synthesis to support increased proliferation 
[16]. Whether this is true for PSCs is still an open question. Importantly, the switch of 
energy generation from glycolysis to oxidative phosphorylation is sufficient to induce 
differentiation in PSCs [8], suggesting a role of glycolysis in PSC self-renewal. Other 
metabolic pathways, including lipid metabolism, have also shown to be enriched in PSCs 
and have been modulated to enhance iPSC reprogramming efficiency [17•].
One of the mechanisms by which metabolites can directly control PSC fate is by altering the 
epigenetic landscape [4–7•,14,18–20••]. S-adenosyl methionine (SAM) donates methyl 
groups for histone and DNA methylation, and levels of intracellular SAM can regulate 
methylation potential. Several metabolites have been shown to affect SAM levels, including 
methionine and threonine. Deprivation of methionine [5••] or threonine (in mouse ESCs) 
[18,19] in culture medium led to a rapid decrease in SAM and triggered histone and DNA 
demethylation, thereby increasing hPSC differentiation. Extended culture in methionine-
deprived medium resulted in increased apoptosis [5••].
Histone methylation potential of naive human embryonic stem cells (hESCs) is reduced by 
increased activity of nicotinamide N-methyltransferase (NNMT) [6••]. NNMT catalyzes the 
conversion of SAM to 1-methylnicotinamide, which acts as a methyl sink [21] and is 
responsible for low levels of SAM. Histone/DNA demethylation is an equally important 
process in epigenetic regulation and it was shown that the intracellular α-ketoglutarate (α-
KG) to succinate ratio regulates ten-eleven translocation (Tet)-dependent DNA 
demethylation, which is crucial for maintaining pluripotency in mouse ESCs [20••]. Directly 
altering this ratio of α-KG/succinate by supplementation of α-KG supported self-renewal 
while supplementation of succinate promoted differentiation, providing further evidence for 
metabolic regulation of pluripotency in mouse ESCs [20••].
Moussaieff et al. [7•] provided evidence that glycolytic acetyl-CoA affects histone 
acetylation in hPSCs. The authors showed that glycolytic production of acetyl-CoA 
promoted histone acetylation in PSCs and that modulation of glycolysis was sufficient to 
regulate pluripotency [7•]. There are several other metabolites which affect histone 
acetylation [22] and abundances of these metabolites can, therefore, affect PSC fates. 
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Metabolites that affect histone post-translational modifications, such as acetylation, 
methylation, and phosphorylation, will also likely regulate global protein modifications that 
modulate stem cell pluripotency and differentiation. Onjiko et al. [9•] used single cell 
capillary electrophoresis-electrospray ionization mass spectrometry to show that different 
cell types in the 16-cell embryos of the South African clawed frog contained different 
quantities of metabolites. Additionally, changing metabolite concentrations altered cell 
migration during gastrulation, which in turn influenced the differentiation fates of these 
cells, indicating the importance of the balance of metabolites in determining the fates of 
stem cells during development [9•]. Overall, these studies highlight the important role 
metabolite concentrations play in regulation of protein post-translational modifications, 
epigenetics, and pluripotency and differentiation fates in stem cells.
Metabolism affects maturation of PSC-derived cells
In addition to regulation of stem cell fate, recent studies have also highlighted an important 
role of metabolism in maturation of hPSC-derived cell types [23••,24•]. For example, adult 
cardiomyocytes (CMs) primarily utilize fatty acid metabolism while immature hPSC-CMs 
rely on oxidative phosphorylation for energy generation [25]. A recent study by Kuppusamy 
et al. [23••] identified that the let-7 family of miRNAs (let-7i and let-7g) are upregulated in 
adult CMs. They showed that overexpression of let-7 miRNAs, whose targets involve genes 
in fatty acid metabolism and oxidative phosphorylation pathways, promoted maturation of 
hESC-CMs accompanied by a metabolic switch to fatty acid oxidation [23••].
Similarly, hPSC-derived hepatocytes exhibit different toxicity responses than adult human 
hepatocytes [26]. For example, hPSC-derived hepatocytes express lower levels of 
cytochrome P450 (CYP450), which is important for metabolic transformation of lipids and 
for xenobiotic transformation, than adult hepatocytes [27]. Avior et al. [24•] observed 
metabolic maturation driven by microbial-derived metabolites, including lithocholic acid and 
vitamin K2, in hPSC-derived hepatocytes. They observed greater than 8-fold induction of 
CYP450 expression and were able to predict the TC50 (concentration causing 50% cell 
death) for several toxins with very high accuracy. These studies highlight the significant role 
metabolites and metabolic pathways play in maturation of hPSC-derived cell types. A 
summary of the effects of metabolites and pathways on altering the PSC fate is shown in 
Figure 1.
Identifying metabolic signatures and biomarkers via metabolomics
Cell types can be characterized by distinct and unique metabolite profiles. Several studies 
have profiled metabolite changes in hPSCs and hPSC-derived cells [8,11,28–30]. Yanes et 
al. [8] showed distinct metabolic changes in hESCs on differentiation to ectoderm and 
mesoderm and identified metabolic pathways that regulate hPSC differentiation. For 
example, eicosanoid pathway inhibition maintained pluripotency while substrates for 
oxidative metabolism, including fatty acids and acyl carnitines, promoted neurogenesis and 
cardiogenesis [8]. Panopoulos et al. [11], Varum et al. [28] and Meissen et al. [30] identified 
metabolic differences between ESCs, iPSCs and their somatic derivatives. Despite the 
epigenetic and functional similarities of ESCs and iPSCs [31], Panopoulos et al. [11] 
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observed significant metabolic changes in unsaturated fatty acid metabolites, SAM, 
hypoxanthine and inosine. Based on gene expression analysis of glucose metabolism 
pathways, oxygen consumption rates and lactate production, Panopoulos et al. [11] and 
Varum et al. [28] concluded that hPSCs primarily relied on glycolysis to meet their energy 
demands. Meissen et al. [30] identified significant metabolic differences in mouse ESCs and 
iPSCs, mainly in amino acids and suggested differences in polyamine pathway activity due 
to significant differences in putrescine and 5-amthylthioadenosine (Table 1).
Dawud et al. [29] found cell type-specific metabolic signatures in hESCs and human 
embryonal carcinoma cells, including differences in cell membrane components, despite 
similarities in concentrations of glycolysis pathway components. Recent studies have also 
reported metabolic signatures of hPSC-derived cell types including hPSC-derived vascular 
endothelial and smooth muscle cells [32], and CMs [33•].
Identifying molecular signatures can be useful in applications including purification of 
specific cell types based on their metabolic pathways [33•], assessing the efficiency of 
generating a target cell type based on the activity of specific pathways [17•] or comparing 
hPSC-derived cells with their primary counterparts [34]. Tohyama et al. [33•] developed an 
approach for purification of mouse and human PSC-derived CMs based on the significant 
differences in the glucose and lactate metabolism between CMs and other cell types. Only 
CMs were able to metabolize lactate in glucose-depleted culture medium and authors were 
able to achieve up to 99% CM purity. Pei et al. [17•] used lipid droplet abundance as a 
marker for reprogramming and determined that Rab32 improved iPSC reprogramming 
efficiency by enhancing lipid biosynthesis.
Metabolomics in iPSC-based disease modeling
Recent studies have employed disease-specific iPSC models to study the metabolic changes 
the disease state imparts on specific cell populations [35–37]. For example, Paulsen et al. 
[35] demonstrated that neural progenitor cells (NPCs) differentiated from iPSCs 
reprogrammed from schizophrenia (SZP) patients generated more reactive oxygen species 
(ROS) and consumed more oxygen compared to NPCs derived from control iPSC lines. 
Importantly, this difference was only evident in NPC-SZP and not the patient fibroblasts or 
undifferentiated iPSCs. Interestingly, valproate treatment was able to restore the ROS levels 
similar to control, however extramitochondrial oxygen consumption was significantly 
increased due to valproate treatment in both NPC-control and NPC-SZP.
Imazumi et al. [36] and Cooper et al. [37] generated iPSCs from Parkinson’s disease (PD) 
patients harboring mutations in PARK2 [36] or PINK1 and LRRK2 [37] and observed 
several metabolic phenotypes, including increased ROS-mediated stress which led to 
reduced glutathione levels exclusively in iPSC-derived neurons (and not iPSCs or iPSC-
derived fibroblasts) as compared to control iPSCderived neurons [36,37]. The PD iPSC-
neurons also exhibited aberrations in mitochondrial morphology and impaired mitochondrial 
homeostasis [36,37], which was rescued by coenzyme Q10, rapamycin, or the LRRK2 
kinase inhibitor GW5074 [37], further highlighting the value of metabolomics in assessing 
Bhute et al. Page 4













phenotypes in iPSC-based disease models and identifying potential therapeutic targets 
(Figure 2).
Applications of metabolomics in identifying the effects of teratogens on 
PSCs
Several studies have used metabolomics to understand the effects of different drugs on stem 
cell metabolism [13,38–41]. West et al. [13] and Kleinstreuer et al. [38] detected teratogens 
and also identified biomarkers of developmental toxicity by quantifying metabolic changes 
in the hESC secretome in response to drug dosing. Palmer et al. [41] quantified the 
secretome of hESC-derived embryoid bodies, neural progenitors, and neurons in response to 
different doses of ethanol (EtOH) exposure to identify metabolic changes and biochemical 
pathways which play a role in alcohol-induced developmental neurotoxicity. They observed 
statistically significant changes due to EtOH exposure in all the three cell types, although 
none of the responses were common to all cell types. Based on these results, the authors 
suggested 5’-methylthioadenosine (MTA) and thyroxine as potential biomarkers for alcohol 
toxicity during early stages of development (Table 1).
West et al. [39] used GC-MS based metabolomics to assess the effects of several steroid 
hormones on the metabolism of hESC-derived germ-like cells and developed models to 
distinguish the effects of different hormones on metabolism. Combining transcriptomic and 
metabolomic analysis, Stechow et al. [40] identified cisplatin-regulated pathways in human 
PSCs, including nucleotide metabolism, the urea cycle, and arginine and proline 
metabolism. Several anti-oxidant associated metabolites and p53-regulated enzymes also 
showed significant enrichment due to genotoxic stress induced by cisplatin. These studies 
highlight the sensitivity of metabolism to drugs and hormones and the potential of hPSCs in 
drug toxicology screening (Figure 2).
Assessing the effect of environment on stem cell metabolism
In addition to studying the effects of drugs, metabolomics has also been used to understand 
the effect of medium components [42,43••], physiological and atmospheric oxygen 
concentrations [44,45•], 2D vs. 3D culture [46], and enzymatic passaging [47] on stem cell 
metabolism. Batch-to-batch variation in media can negatively impact the reproducibility of 
stem cell culture and differentiation. MacIntyre et al. [42] correlated metabolite 
concentrations in conditioned medium by human foreskin fibroblasts (HFFs) at different 
passages to their ability to maintain hESCs in culture (Table 1). HFF metabolism changed 
with extended culture, metabolite content of the conditioned media at different passages may 
account for differences in maintenance capability of hESCs by HFF-conditioned media [42].
Forristal et al. [45•] reported that hESCs cultured at 5% oxygen showed increased glucose 
consumption and lactate production as compared to hESCs cultured at atmospheric 
conditions (20% oxygen). A comprehensive analysis of metabolic fluxes was performed by 
Turner et al. [44] in hESCs cultured in atmospheric vs. hypoxic (2% oxygen) conditions. 
Although hESCs utilized glucose via aerobic and anaerobic glycolysis in both atmospheric 
and hypoxic conditions, they also utilized glutamine as the carbon source for oxidative 
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phosphorylation to maximize the ATP production in atmospheric conditions, with amino 
acids as the major substrates for tricarboxylic acid (TCA) cycle. A recent study by Zhang et 
al. [43••] also reported the ability of hPSCs to utilize the TCA cycle in addition to glycolysis 
for energy generation depending on the availability of lipids in the media (Table 1).
Azarin et al. [46] studied the impact of 2D vs. 3D culture of hESCs on their cell cycle and 
metabolism and observed negligible changes in lactate-glucose ratios due to 3D culture, 
although they did report that 100 μm diameter hESC colonies contained higher lactate-
glucose ratios than larger 3D colonies; the smaller colonies also exhibited less spontaneous 
differentiation than larger colonies [48], perhaps indicating a relationship between lactate-
glucose ratio and hPSC self-renewal. Similarly, different methods of enzymatic passaging of 
hPSCs resulted in reduction of lipogenesis and glucose utilization in the central carbon 
metabolism as compared to non-enzymatic dissociation [47] (Table 1). Together, these 
studies demonstrate that identifying hPSC metabolic responses to culture conditions can be 
used to improve culture efficiency and robustness.
Conclusions and Future Perspectives
Recent studies have proven that metabolic changes and metabolite abundances can regulate 
PSC fates by affecting the epigenetic landscape in stem cells [4,5,18]. Patient-derived iPSCs 
are increasingly being used as in vitro models [49] to identify these metabolic alterations 
and predict new therapeutic targets to reverse or rescue the metabolic dysfunction in 
diseases. Advances in genome editing technologies like CRISPR-Cas9 can also be used to 
introduce mutations to study the effects of genetic disease on metabolism [50]. Recent 
studies have shown that understanding unique metabolic requirements can be used to 
develop strategies for efficient purification of specific cell types [33•] and that metabolic 
pathways play critical role in regulating cell maturation [23••]. Combining metabolomics 
with metabolic flux analysis (MFA) has the potential to provide deeper insight into how 
differentiation affects metabolism in stem cells and should prove useful in developing 
strategies to enhance pluripotency or differentiation fates in stem cells by modulating 
metabolic pathways [20••,43••,47,51].
There are numerous successful demonstrations of the application of metabolomics for 
toxicological screening in PSCs and PSC-derived cells, especially in studying developmental 
disorders [13]. Metabolomics has also been used to understand and optimize the impact of 
culture conditions on stem cell maintenance and differentiation. Different aspects of stem 
cell biology can also be assessed using metabolomics, including profiling the secretome and 
investigating interactions between stem cells and other cell types or substrates, and probing 
effects of geometry, organization, and density of stem cells in 2D and 3D culture. Advances 
in spectroscopic techniques have improved the sensitivity and reproducibility of 
metabolomics data, yet several challenges remain [10]. Even though we are able to measure 
metabolites to picomolar sensitivity using mass spectrometry approaches, accurate 
identification of these metabolites is still a challenge [10]. Differences in experimental 
methods, cell status, profiling approaches, and data processing and analysis have to be 
considered when comparing metabolic signatures. In the stem cell field, where the media 
and culture conditions can vary from lab to lab and are continually evolving, comparing 
Bhute et al. Page 6













results from different studies is particularly difficult. Detailed guidelines for sample 
preparation and analysis can overcome some of these challenges [52]. When combined with 
other -omics approaches, metabolomics promises to offer unprecedented insight into 
interactions between metabolic and signaling pathways that regulate stem cell fate.
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• Metabolism regulates stem cell fate by altering epigenetic markers
• Metabolite signatures can be used to characterize differences between cell 
types
• Metabolomics can be used to identify biomarkers of developmental toxicity to 
drugs
• Metabolomics has also been used to optimize stem cell culture conditions
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Figure 1. Regulation of PSC fate and maturation by metabolites and metabolic pathways
Epigenetic regulation plays a significant role in maintaining the pluripotent state of PSCs. 
For example, histone methylation and acetylation is affected by specific metabolites. Stem 
cells also show increased abundance of unsaturated metabolites and inhibition of the 
eicosanoid pathway can assist in maintenance of pluripotency. During differentiation, 
metabolism shifts from glycolysis to oxidative phosphorylation or fatty acid oxidation 
accompanied by a reduction in unsaturated metabolites. Metabolic pathway regulation can 
drive maturation of hPSC-CMs and hPSC-derived hepatocytes. Abbrev. SAM: S-adenosyl 
methionine, NNMT: Nicotinamide N-Methyltransferase, 1-MN: 1-methylnicotinamide, 
CoA: coenzyme A, CM: cardiomyocyte
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Figure 2. Applications of metabolomics in drug discovery using PSCs
Patient-derived iPSCs can serve as in vitro models for drug screening and identifying the 
metabolic consequences of disease-related genetic mutations. PSCs can also serve as models 
to assess developmental toxicity of several drugs and quantify the teratomagenicity of 
compounds. Abbrev. iPSCs: induced pluripotent stem cells, SZP: schizophrenia, PD: 
Parkindon’s disease, PSCs: pluripotent stem cells, ROS: reactive oxygen species
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Table 1
Summary of application of metabolomics to analyze the effects of culture conditions, drugs, and teratogens on 












Unsaturated fatty acids ↓; SAM ↑, inosine









Octadecenoic acid ↑, glycerol-3-
phosphate ↑, 4-hydroxyproline ↑,
glutamic acid ↓, mannitol ↓, malic acid ↓,









Arginine to asymmetric dimethylarginine
(ADMA) between 0.9 and 1.1 for non-
teratogens (except for ascorbic acid and
caffeine), GABA and malate are
increased while succinate is reduced due
to teratogens
(supernatant)
H9 (hESC) LC-MS [13,38]
Ethanol Embryoid bodies: MTA ↓ at higher dose
and succinyladenosine ↑ at both low and
high dose, thyroxine ↑ at lower dose
Neural Progenitors: Kynurenine ↑ at
lower dose of EtOH








Estrogen: Lactate ↑, aspartate ↓, lysine ↓,
phospholipids ↓, threonine ↓, valine ↓
Testosterone: Glycerol ↑, glycogen ↑,
valine ↓
Progesterone: Organic acids ↓,
phenylalanine ↓, proline ↓, tyrosine ↓
Common: Glucose ↑ and fatty acids ↓,






Cisplatin Oxidized and reduced glutathione ↑, urea
↑, proline ↑, putrescine ↑, spermine ↑,
SAM ↑, several nucleotides were also
altered
(intracellular)








Higher lactate, alanine, formate and lower
tryptophan in HFF conditioned media
which supported hESC maintenance
(supernatant)
H9 (hESC) NMR [42]
5% vs. 20%
oxygen
Increased glucose consumption and










In addition to glycolysis, also utilized
glutamine and amino acids for energy
generation using oxidative








Metabolic rewiring takes place depending
on nutrient availability and in addition to





























2D vs. 3D Higher lactate-glucose ratios in small







Enzymatic passaging led to reduction of
lipogenesis and glucose utilization
(intracellular)
H9 (hESC) GC-MS [47]
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